Subclinical Atherosclerosis and Endothelial Dysfunction in Cases of Systemic Lupus Erythematosus: A Hospital-Based Case-Control Study

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 8; p. e67473
• Main Authors: Biswas, Tapobrata, Tarenia, Silima, Bera, Sudipta, Naiya, Sourav, Acharya, Sourya, Shukla, Samarth, Kumar, Sunil, Pantbalekundri, Nikhil, Giri, Anamika G
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 22.08.2024; Cureus
• Subjects: Age groups; Atherosclerosis; Disease; Hospitals; Hypertension; Inflammation; Internal Medicine; Lupus; Pathology; Rheumatology; Ultrasonic imaging; Veins & arteries; atherosclerosis; fmd; endothelial dysfunction; sle; carotid intima-media
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.67473

Background Women are more likely to be affected with systemic lupus erythematosus (SLE), a chronic multisystem inflammatory autoimmune illness. It is well established that SLE increases the risk of cardiovascular (CV) events. This study aimed to determine the prevalence of endothelial dysfunction and subclinical atherosclerosis in patients with SLE. If these conditions are identified early, suitable preventative measures may be advocated to lessen the burden of future CV events. Aim This study aims to calculate the frequency of endothelial dysfunction and subclinical atherosclerosis in SLE patients using the flow-mediated dilatation (FMD) of the brachial artery and carotid intima-media thickness (c-IMT). Results There were 50 confirmed cases of SLE. Compared to healthy controls, SLE patients' c-IMT readings were higher, suggesting subclinical atherosclerosis. Thirty-three patients with c-IMT values >0.06 (p<0.00269) out of 50 SLE cases were found to have a high prevalence of subclinical atherosclerosis. Five SLE patients showed FMDs of less than 4.5% (p<0.021) compared to healthy controls, indicating preclinical atherosclerosis with endothelial dysfunction. It was discovered that endothelial dysfunction exhibited a positive linear connection with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) when contrasted with traditional inflammatory indicators such as ESR and CRP. Conclusion Patients with SLE face a higher risk of CV events and mortality compared to those without the condition. They are also more prone to developing endothelial dysfunction and subclinical atherosclerosis. Detecting these issues early can help in implementing primary and secondary prevention strategies effectively.